Cancel

Diabetic Macular Edema: Employing Inflammatory Markers to Predict Improved Visual Outcomes

Real-world outcomes with intravitreal anti-vascular endothelial growth factor (VEGF) therapy in the treatment of patients with diabetic macular edema (DME) do not always replicate those seen in clinical studies. In part, these discrepancies are due to treatment burden, lack of adherence, undertreatment, and incomplete response to anti-VEGF therapies. The identification of several inflammatory cytokines in the aqueous and vitreous humor whose concentrations correlate closely with the severity o...
Vindico Medical Education

Introduction to Culturally and Linguistically Appropriate Services (CLAS) and Minority Health Disparities

This course helps you incorporate into practice the National Culturally and Linguistically Appropriate Services (CLAS) standards of the USDHHS Office of Minority Health. Outcome Objectives: As a result of completing this activity, the participant will be better able to: - Describe the National Culturally and Linguistically Appropriate Services (CLAS) standards of the USDHHS Office of Minority Health and how they impact the ethical responsibilities of medical service providers. - Defi...
Virtual Lecture Hall (University of Arizona College of Medicine - Tucson)

Skin Cancer Education for Primary Care

This comprehensive course on skin cancer will help you improve your ability to diagnose and manage skin lesions, the most common of all cancers. Outcome Objectives: As a result of completing this activity, the participant will be better able to: - Understand the biology of ultraviolet radiation and methods to protect the skin. - Demonstrate increased proficiency in the management of potentially malignant skin lesions. - Make early diagnoses of skin cancers, particularly melanoma....
Virtual Lecture Hall (University of Arizona College of Medicine - Tucson)

The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease

This session will evaluate the safety of opioid therapy among patients with chronic obstructive pulmonary disease (COPD). The session will cover existing safety and effectiveness evidence from clinical trials, and present the latest data from observational studies. The presentation will include a discussion of the strengths and disadvantages of observational study designs along with implications for future practice. Approximately 15.7 million Americans (6.4%) currently are diagnosed with CO...
CEimpact

Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 1: Currently Available Injectable Biologic Therapies for Moderate-to-Severe Atopic Dermatitis (AD)

Target Audience This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis. Program Overview This activity features a case presentation, a brief overview of currently available injectable biologic therapies, and insights from an expert faculty. Learning Objectives After completing this activity, the participant should be better able to:: Identify ...
Relias LLC

Infectious Diseases in Adults 2024 - LIVE STREAMING

State-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases This comprehensive Harvard Medical School CME program"one of the highest-rated HMS CME courses"ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis, and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: ...
Harvard Medical School

nAMD and DME Management: Rapid Response From ARVO

Real-world outcomes with anti-vascular endothelial growth factor (VEGF) therapies in the management of patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) are often not comparable to those of clinical studies. Discrepancies in these outcomes have been associated with undertreatment due to high treatment burden and the associated loss of patient adherence to dosing schedules. Newer therapies with novel mechanisms that extend intervals between dosing...
This continuing education activity is provided by Vindico Medical Education.

nAMD and DME Management: Rapid Response From ARVO

Real-world outcomes with anti-vascular endothelial growth factor (VEGF) therapies in the management of patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) are often not comparable to those of clinical studies. Discrepancies in these outcomes have been associated with undertreatment due to high treatment burden and the associated loss of patient adherence to dosing schedules. Newer therapies with novel mechanisms that extend intervals between dosing...
This continuing education activity is provided by Vindico Medical Education.

Geographic Atrophy: Rapid Response from ARVO

Geographic atrophy (GA) is a pathological deterioration of the retina seen in the late stages of age-related macular degeneration (AMD). It affects 20% of people with AMD, and its prevalence increases exponentially with age. Until recently, there were no treatment options for GA, but investigation into the complement system and its role in the pathogenesis of GA has led to targeted therapies that have revolutionized the treatment paradigm. Because of the recent approval of one of these therapi...
This continuing education activity is provided by Vindico Medical Education.

9th Annual Clinical Issues in Primary Care Conference

Presented by Continuing Education Company for over 30 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us in May 2024 for our 9th Annual Clinical Issues in Primary Care Conference at the Fairmont Orchid, Hawaii Resort on the Big Island Program Objectives As a result of this conference, participants will be able to: Assess and p...
Continuing Education Company

Anesthesiology Update 2024 - LIVE STREAMING or IN PERSON

The Comprehensive 2024 Anesthesiology Update Cardiac, Regional, Office-Based, Thoracic, Obstetric, Neuro, and Pediatric Anesthesiology Update will be held on May 6-10, 2024. You have the option to attend either online as the course is live streamed or in person in Boston, MA. In the past year, there have been a number of very significant clinical changes that affect the practice of anesthesiology. This comprehensive CME program provides a special and timely opportunity for anesthesiolo...
Harvard Medical School

A Class Act in Glaucoma Management: Differentiating Rho Kinase Inhibitors From the Pack

Medical management of glaucoma primarily focuses on lowering intraocular pressure (IOP) by decreasing aqueous production, reducing episcleral venous pressure, and/or increasing uveoscleral and trabecular outflow. Recently approved agents have expanded treatment options beyond the traditional mainstays of prostaglandin analogues and β-blockers, engaging Rho kinase (ROCK) inhibition to improve outcomes for patients with glaucoma. In this CE monograph, experts in the field will review the clinic...
This continuing education activity is provided by Vindico Medical Education.

Diabetes Update 2024 - LIVE STREAMING

This highly rated Harvard Medical School CME course offers practical strategies to address the medical and systemic challenges to optimal care and updates that ensure you can deliver state-of-the-art care for your patients with diabetes. PROGRAM HIGHLIGHTS This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care. Participants can rely on this program for compreh...
Harvard Medical School

Hot Topics in Lupus: SLE Pathophysiology

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label immunosuppressants, can be implemented in customized ways to mitigate or eliminate the use of glucocort...
Integritas Communications

Hot Topics in Lupus: Individualizing Steroid-Sparing Regimens

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label immunosuppressants, can be implemented in customized ways to mitigate or eliminate the use of glucocort...
Integritas Communications

Hot Topics in Lupus: Targeted Biologic Treatment Options

Despite the known short- and long-term adverse outcomes related to glucocorticoid use, patients with SLE are still taking moderate to high daily doses of steroids. Fortunately, 2 biologic therapies aimed at different therapeutic targets in the type I interferon pathway and with better safety profiles than glucocorticoids are currently available for use. These biologics, along with off-label immunosuppressants, can be implemented in customized ways to mitigate or eliminate the use of glucocort...
Integritas Communications

EGPA Expert Exchange " A Podcast Series on Eosinophilic Granulomatosis With Polyangiitis

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg-Strauss syndrome, is a rare form of vasculitis that primarily affects the small blood vessels. Individuals diagnosed with EGPA commonly have a history of asthma and/or allergies. Eosinophilic inflammation associated with EGPA can lead to injury in multiple organ systems, including the sinuses, lungs, gastrointestinal system, heart, nervous system, and kidneys. Accurate diagnosis and treatment are critical to minimize g...
This continuing education activity is provided by Vindico Medical Education.

Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease

Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and subsequently undertreated. Studies have demonstrated that meibomian gland dysfunction (MGD) is a leading cause of the development and progression of evaporative DED, caused by a deficient tear film lipid layer that leads to increased tear evaporation. New and emerging treatments with novel mechanisms of action are being investigated that manage the signs and symptoms of DED associated with MGD and offer the potential f...
This continuing education activity is provided by Vindico Medical Education.

Case Challenges in nAMD and DME Management: Achieving Durable Response

The management of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with intravitreal anti-vascular endothelial growth factor (VEGF) therapies has provided enhanced visual outcomes for many patients. However, the high treatment burden associated with anti-VEGF therapies can lead to lack of patient adherence, resulting in suboptimal outcomes. Personalized treatment protocols using FDA-approved agents and newer novel delivery systems, along with agents with uni...
This continuing education activity is provided by Vindico Medical Education.

Optimizing Transition from Pediatric to Adult Care - LIVE STREAMING

In this special program, faculty from Harvard Medical School, the Brigham Transition Care Team, and the Boston Children’s Hospital BRIDGES Adult Transition Program provide strategies, best practices, and guidance to: • Identify adult care providers and successfully transfer patients with rare or complex health care needs • Assess and improve the efficacy of your current transition processes • Tailor transition strategies to patient age, disease type, and physical/ intellectual capab...
Harvard Medical School

Adaptive Learning to Improve Individualized Management of Type 2 Diabetes (T2D)

As a primary care provider, you play a critical role in the management of patients with type 2 diabetes. ACHL AdaptED® offers a unique experience designed to meet the needs of busy clinicians seeking to enhance their expertise in this area. Our adaptive learning platform allows you to tailor your educational experience to match your specific learning goals and knowledge gaps. This activity has you covered whether you're looking to deepen your understanding of the latest treatment options...
ACHL

Optimizing Outcomes in ALS: Best Practices in Screening, Diagnosis, and Treatment

"Optimizing Outcomes in ALS: Best Practices in Screening, Diagnosis, and Treatment" is a modular continuing education series led by Dr. Richard Bedlack, a nationally recognized ALS expert. This self-navigation program focuses on amyotrophic lateral sclerosis (ALS), providing healthcare professionals with valuable insights and evidence-based strategies to enhance outcomes in ALS care. Participants have the flexibility to choose their own track and explore various modules, covering cli...
Annenberg Center for Health Sciences at Eisenhower

NeuroRehabilitation 2024 - LIVE STREAMING

Comprehensive Neurorehabilitation Update Cutting-edge strategies, updates, and best practices for state-of-the-art rehabilitation In this course, which is among the highest-rated Harvard Medical School CME courses, many of the country’s most experienced and committed neurorehabilitation experts will present cutting-edge clinical interventions, the latest findings, practical education, and hands-on methods to further your expertise in guiding your patients with stroke, SCI, TBI, brain t...
Harvard Medical School

Comprehensive Sterile Compounding

June 6th - 8th, 2024 COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding. Physicians and other healthcare professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy to compound sterile preparations. Participants are instructed in the proper aseptic techniques...
American College of Apothecaries

WEBINAR BUNDLE: Veterinary Pharmacy Conference 2021 - On Demand

Earn up to 7 hours of continuing education focused on community veterinary pharmacy when you purchase the Veterinary Pharmacy Conference 2021 - On Demand. The ACVP Veterinary Pharmacy Virtual Conference is the only national conference designed exclusively for community veterinary pharmacies, ideal for new and established veterinary pharmacy practices. This conference is designed for pharmacists and pharmacy technicians and presents the latest clinical and practical topics. Session 1 -...
American College of Veterinary Pharmacists

WEBINAR: Metronomic Chemotherapy: Hope vs. Hype

Metronomic chemotherapy has become quite popular with oncologists and general practitioners. There are some basic scientific data addressing its mechanism of action, however, the vast amount of data is purely retrospective in nature. These studies vary in drug dosage and protocols used making assessment between studies challenging. On top of this, there are no good surrogate markers for efficacy to help guide clinicians. Last, the use of metronomic therapy has opened our eyes to the challenges...
American College of Veterinary Pharmacists

Graft vs Host Disease: Novel Management Strategies for a Chronic Condition

Target Audience The intended audience for this activity is transplant specialists, oncologists, hematologists, and other healthcare professionals involved in the treatment of patients with GVHD. Program Overview This enduring activity takes learners on a compelling journey in managing chronic graft-versus-host disease (cGVHD) by explaining the evidence-based diagnostic criteria for cGVHD for prompt diagnosis; discussing the clinical safety and efficacy data of recently approved and invest...
Med Learning Group

A Breath of Fresh Air: Novel Treatments That Address the Inflammatory Component of Non-Cystic Fibrosis Bronchiectasis

Non-cystic fibrosis bronchiectasis (NCFBE) is a heterogenous and increasingly prevalent chronic pulmonary disease that is associated with high morbidity and mortality. It is characterized by irreversibly damaged and dilated bronchi, and has a broad spectrum of clinical presentations, ranging from asymptomatic radiological changes detected incidentally to chronic sputum production and recurrent exacerbations. There are numerous etiologies that can induce or contribute to the pathophysiological ...
This continuing education activity is provided by Vindico Medical Education.

State-of-the-Art Obesity Management in the Primary Care Setting

Access our robust online slide library covering the management of obesity in the primary care setting. Expert faculty in weight management developed content related to epidemiology, pathophysiology, and complications of obesity; screening and diagnosis; patient counseling; case studies; nonpharmacologic therapies; and pharmacologic therapies. Choose your topic interests and customize your own slide deck to broaden your knowledge and improve the care and outcomes of patients with obesity. Ob...
ACHL

In Case You Missed: Utilizing the Muscarinic System to Optimize Treatment Options for Schizophrenia

Schizophrenia is an incurable, neuropsychiatric disease characterized by difficulties thinking and communicating clearly as well as psychosis (ie, “positive” symptoms); difficulty functioning socially (ie, “negative” symptoms); and cognitive impairment. As many as 34% of patients with schizophrenia have treatment-resistant schizophrenia, defined as continuing symptoms despite at least 2 trials of appropriate antipsychotic treatment, and most people do not recover from it. Patients with...
This continuing education activity is provided by Vindico Medical Education.

The Pharmacist’s Role in Managing Patients with Worsening Heart Failure

Pharmacists play a vital role in the management of patients with heart failure (HF). Navigate through this interactive self-directed, pharmacist-targeted activity designed to optimize your decision-making to apply the most recent clinical trial data and guidance seen in real-world HF practice, particularly in patients with worsening HF and after recent HF hospitalization. Expert perspectives and insights cover guideline-directed medical therapy (GDMT) implementation and additional adjustment t...
ACHL

Ultrasound Guided Vascular Access - Blended

The Blended Ultrasound Guided Vascular Access Training Course is planned in accordance with the current Agency for Healthcare Research and Quality (AHRQ), ACEP, and WINFOCUS guidelines and provides participants a strong foundation to perform central and peripheral line techniques in an emergency setting. The Blended Education format provides flexibility while saving you time and minimizing travel costs. Begin with the self-paced online course: Taught by leading emergency medicine ultrasound...
Gulfcoast Ultrasound Institute

28th Annual Hypertension, Diabetes & Dyslipidemia Conference

This three day intensive conference, held on June 19-21, 2024 in Charleston, South Carolina, addresses all the issues confronting clinicians who treat challenging patients with diabetes, hypertension, and dyslipidemia and how to apply this knowledge to everyday practice. Over the past several years controversies in the appropriate target for Hemoglobin A1C, BP, and LDL-Cholesterol on outcome improvement continue to occur in Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Desp...
Continuing Education Company

Diagnosis and Management of Patients With Predominant Skin Symptoms

The educational design of this activity addresses the needs of allergy/clinical immunology, gastroenterology, dermatology, and hematology clinicians who manage patients with nonadvanced systemic mastocytosis. Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and ...
Integritas Communications

32nd Annual Primary Care Conference, Session 1

Continuing Education Company has been organizing its Primary Care Conference Series for over 31 years. The Primary Care Conference is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us this June or July when we hold the 32nd Annual Primary Care Conference. This conference will be repeated in two sessions for convenience in scheduling. Sessions I and II will be held at the Kiawah Is...
Continuing Education Company

How I Treat Paroxysmal Nocturnal Hemoglobinuria (PNH)

In this point-counterpoint digital activity, two expert faculty discuss and debate treatment selection for patients with PNH through case-based scenarios. Faculty review mechanisms of action, clinical trial data, and real-world evidence supporting divergent treatment strategies for the presented cases. How do the experts make their initial treatment selections? Why might they choose a C5 inhibitor or a C3 inhibitor? How do they assess response to treatment, and what do they do when treatment r...
ACHL

Navigating New Evidence in the Treatment of HER2-Expressing Metastatic Breast Cancer in Rural and Underserved Communities

Target Audience This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities. Program Overview Over the past decades, the emergence of novel targeted therapies in combination with endocrine therapy has improved outcomes for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. However, oncology clinicians in rural and ...
Postgraduate Institute for Medicine and RME Collaborative.

Navigating the Evolving Treatment Landscape of Renal Cell Carcinoma to Ensure Equitable Access to Quality Care

Target Audience This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities. Program Overview Therapeutic options for metastatic renal cell carcinoma (RCC) have expanded over the last decade and now include targeted therapies as well as immunotherapies. However, workforce shortages, low rates of recruitment into clinical trials, racial and socioeconomic inequities, a...
Talem Health and RME Collaborative.

Integrating PARP Inhibitors Into Treatment for Advanced Ovarian Cancer: Strategies for Improving Care and Outcomes

Target Audience This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities. Program Overview In recent years, the emergence of novel therapeutic agents has led to improved outcomes for patients with advanced and/or platinum-resistant ovarian cancer. Yet, even with improved treatment options, oncology teams in rural and underserved settings are challenged to provide ...
Postgraduate Institute for Medicine and RME Collaborative.

Gastroenterology 2024 - LIVE STREAMING

The Comprehensive 2024 Gastroenterology Update This highly rated Harvard Medical School CME program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians. Practical, Results-Driven Education Highlights of the 2024 program include: • Updated...
Harvard Medical School

Internal Medicine Comprehensive Review and Update 2024 - LIVE STREAMING

Comprehensive, Evidence-Based Updates for Internal Medicine and Its Subspecialties This program, the 64th annual Internal Medicine Update from the leading clinical faculty of Harvard Medical School and Massachusetts General Hospital, provides comprehensive, high-yield instruction to ensure clinicians are current with the latest evidence and best practices to optimize patient care. This program covers the breadth of Internal Medicine subspecialties, including: • Cardiovascular Medicine ...
Harvard Medical School

Treating Obesity 2024: The Blackburn Course in Obesity Medicine - LIVE STREAMING

Education to Optimize Your Care of Adult, Adolescent, and Pediatric Patients with Obesity This highly rated Harvard Medical School CME course delivers practical strategies to optimize the management of obesity and its many complications, and provides the most up-to-date approaches to obesity prevention and treatment. Highlights of the 2024 program include: • Update on using the newer GLP-1 based therapies • Comprehensive evaluation of the patient with obesity • Emerging precision me...
Harvard Medical School

Lifestyle Medicine: Tools for Promoting Healthy Change - LIVE STREAMING

State-of-the-Art Approaches to Help Patients Initiate and Sustain Health-Promoting Behaviors Lifestyle Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. Overview This immersive two-day course offers state-of-the-art strategies to guide patients to healthier lives. Education includes evidence-based strategies, tools and techniques to effect healthier changes in patients (and ourselves), including weight loss, exerci...
Harvard Medical School

32nd Annual Primary Care Conference, Session 2

Continuing Education Company has been organizing its Primary Care Conference Series for over 31 years. The Primary Care Conference is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us this June or July when we hold the 32nd Annual Primary Care Conference. This conference will be repeated in two sessions for convenience in scheduling. Sessions I and II will be held at the Kiawah Is...
Continuing Education Company

15th Annual Essentials in Primary Care Summer Conference

Continuing Education Company has been organizing its Primary Care Conference Series for over 30 years. The Essentials in Primary Care Summer Conference is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Join us this July when we hold the 15th Annual Essentials in Primary Care Summer Conference. This conference will be held at the Hammock Beach Resort in Palm Coast, Florida. Located n...
Continuing Education Company

Right Treatment, Right Patient: Evidence-Based Approaches to the Treatment of Moderate-to-Severe Atopic Dermatitis Snippet 2: Currently Available Oral Therapies for Moderate-to-Severe Atopic Dermatiti

Target Audience This activity is designed to meet the educational needs of dermatology and allergy physicians, nurse practitioners, PAs, and nurses who care for patients with moderate-to-severe atopic dermatitis. Program Overview This activity features a case presentation, a brief overview of currently available oral therapies, and insights from expert faculty. Learning Objectives After completing this activity, the participant should be better able to:: Identify the biologic prope...
Relias LLC

Pathways for Optimal Sequencing, Rapid Initiation, and Titration of Therapy in Patients with Heart Failure

Many patients with heart failure (HF) do not receive foundational treatment although these therapies reduce morbidity and mortality risks. The initiation and optimization of guideline-directed medical therapies (GDMT) can be challenging, but clinical practice guidelines and algorithms are available to assist. Navigate through this interactive self-directed CME activity to apply the most recent clinical trial data and guidance to patient-specific factors seen in real-world practice. Expert p...
ACHL

Call to Action for Health Equity: Racial Disparities in the Care of Patients with Cardiometabolic Disease

Cardiovascular disease is the leading cause of death for adults in the US. However, patients from minority populations with cardiovascular disease have disproportionately poor health outcomes and are particularly vulnerable to health disparities. Racial inequities in health also result in higher risk-burden in minority groups for metabolic syndromes such as Type 2 (adult-onset) diabetes, which increase the risk of cardiovascular disease. Health disparities in cardiometabolic care predominantly...
CME Outfitters

Making the Call in Nonadvanced Systemic Mastocytosis Optimizing Multidisciplinary Management

Series Overview Nonadvanced systemic mastocytosis (SM) is a group of rare disorders characterized by mast cell accumulation that results in a significant and varied symptomatic burden to the patient. The most prevalent of these symptoms include gastrointestinal symptoms, dermatological symptoms, and recurrent anaphylaxis in response to a variety of triggers such as food, insect venom, and medications. In this Phone-a-Friend series, a multidisciplinary panel of faculty experts will address the...
Integritas Communications

Answers to the Questions You May Not be Asking: Treating Ulcerative Colitis Considerate of Patient-Centric Factors

Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strategies such as treat-to-target (T2T) and therapeutic drug monitoring (TDM) for the treatment for your ...
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map